|
Volumn 42, Issue 3, 2005, Pages 216-219
|
The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
CYTOCHROME P450 1A2;
ALLELE;
ARTICLE;
CORRELATION ANALYSIS;
DRUG BLOOD LEVEL;
ENZYME ACTIVITY;
GENE FREQUENCY;
GENE MUTATION;
GENETIC POLYMORPHISM;
GENOTYPE;
HUMAN;
MAJOR CLINICAL STUDY;
MULTIVARIATE ANALYSIS OF VARIANCE;
PHENOTYPIC VARIATION;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
SMOKING HABIT;
ANTIPSYCHOTIC AGENTS;
CLOZAPINE;
CYTOCHROME P-450 CYP1A2;
EUROPEAN CONTINENTAL ANCESTRY GROUP;
GENE FREQUENCY;
HETEROZYGOTE;
HUMANS;
METABOLIC CLEARANCE RATE;
MULTIVARIATE ANALYSIS;
POLYMORPHISM, GENETIC;
PREDICTIVE VALUE OF TESTS;
SCHIZOPHRENIA;
SMOKING;
|
EID: 18844455524
PISSN: 00045632
EISSN: None
Source Type: Journal
DOI: 10.1258/0004563053857798 Document Type: Article |
Times cited : (55)
|
References (6)
|